Covid Pills

US Government Allocates $3.2 Billion For COVID-19 Antiviral Pills

Ailan Evans

daily caller the free press

The Department of Health and Human Services will invest $3.2 billion to develop and manufacture COVID-19 antiviral medicines, it announced Thursday.

The initiative, funded as part of the American Rescue Plan, is designed to accelerate research into antivirals as well as build platforms for urgent response to future viral threats, the Department of Health and Human Services (HHS) said in a statement Thursday. Specifically, the plan expands antiviral clinical trials, forms partnerships between health agencies and pharmaceutical companies, and funds “drug discovery groups” tasked with innovating new antiviral medicines.

“New antivirals that prevent serious COVID-19 illness and death, especially oral drugs that could be taken at home early in the course of disease, would be powerful tools for battling the pandemic and saving lives,” said chief medical adviser Dr. Anthony Fauci in the statement.

Antiviral drugs work by preventing the coronavirus from replicating and spreading, impeding the virus’s infection process, according to The New York Times. Antivirals are most effective in the early days of infection when the virus hasn’t yet spread throughout the body.

While research efforts will initially be focused on COVID-19 antivirals, the door is left open to “other viruses with pandemic potential”, according to the statement.

The plan also introduces a framework for prioritizing antiviral medicines for Food and Drug Administration authorization and approval. This comes following the Biden administration’s purchase of 1.7 million antivirals from pharmaceutical giant Merck, which has yet to go through pending FDA authorization.

“Our administration is going to harness the power of American ingenuity to spur the creation and development of these drugs that can save lives both here in the United States and around the world,” said Dr. David Kessler, Chief Science Officer of the administration’s COVID-19 response team, in the HHS’s statement.

The initiative follows in the footsteps of the Trump administration’s Operation Warp Speed, in which health agencies, pharmaceutical companies, and regulatory bodies collaborated to develop, manufacture, and approve COVID-19 vaccines.

“The remarkable and rapid development of vaccines and testing technology has shown how agile scientific discovery can be when we combine the resources of public agencies, private entities, and our nation’s most brilliant and creative minds,” said Dr. Francis S. Collins, NIH Director, in reference to the operation.

Support journalism by clicking here to our gofundme or sign up for our free newsletter by clicking here

Android Users, Click Here To Download The Free Press App And Never Miss A Story. It’s Free And Coming To Apple Users Soon.

Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact

Login To Facebook To Comment